Second tier markets in biotech

Wednesday, December 08, 2004

Maine recently completed a site analysis for biomed facilities, and the report holds some promise for second tier cities. According to the report's author, John Boyd of the Boyd Company, Inc.:

"There's a shift from large, (cost) prohibitive markets like Boston, Princeton and Atlanta to smaller markets with low cost-of-living indexes, low tax structures, low cost of doing business. Really, it's no secret. There's an exodus away from the large cities, especially with respect to California."

Read more
. Here's some additional background.

posted by Ed Morrison |

Subscribe with Bloglines






Creative Commons License
This work is licensed under a Creative Commons License.
links
Google
The Web EDPro Weblog